Inflammopharmacology

, Volume 21, Issue 1, pp 67–78 | Cite as

Involvement of p38 MAPK-dependent activator protein (AP-1) activation in modulation of gastric mucosal inflammatory responses to Helicobacter pylori by ghrelin

Research Article

Abstract

A peptide hormone, ghrelin, plays an important role in modulation of gastric mucosal inflammatory responses to Helicobacter pylori infection by controlling the cross-talk between nitric oxide synthase (NOS) and cyclooxygenase (COX) enzyme systems. In this study, we report that H. pylori LPS-elicited induction in gastric mucosal COX-2 and inducible (i) iNOS protein expression, and the impairment in constitutive (c) cNOS phosphorylation, was associated with mitogen-activated protein kinase, c-Jun N-terminal kinase (JNK), extracellular signal-regulated kinase and p38 activation, and occurred with the involvement of transcription factors, CCATT/enhancer-binding protein (C/EBP) δ, cAMP response element-binding protein, activator protein-1 (AP-1), and NF-κB. The modulatory effect of ghrelin on the LPS-induced changes was manifested in the inhibition of nuclear translocation of p65 NF-κB and C/EBPδ, and suppression in AP-1 activation, and the inhibition in phosphorylation of JNK and p38, as well as their respective downstream targets, c-Jun and ATF-2. However, only the inhibition of p38-mediated ATF-2 phosphorylation was reflected in the reduced expression of COX-2 protein. Further, the effect of ghrelin of the LPS-induced changes was reflected in the increase in Src/Akt-dependent cNOS activation through phosphorylation and the inhibition of cNOS-mediated IKK-β S-nitrosylation. Our findings indicate ghrelin counters the proinflammatory consequences of H. pylori by interfering with the p38/ATF-2-induced AP-1 activation in association with concurrent up-regulation in Src/Akt-dependent cNOS phosphorylation.

Keywords

H. pylori Gastric mucosa NOS COX Ghrelin S-nitrosylation p38 kinase AP-1 NF-κB 

References

  1. Backert S, Neumann M (2010) What a disorder: proinflammatory signaling pathways induced by Helicobacter pylori. Trends Microbiol 18:479–486PubMedCrossRefGoogle Scholar
  2. Bauer B, Meyer TF (2011) The human gastric pathogen Helicobacter pylori and its association with gastric cancer and ulcer disease. Ulcers 2011(Article ID 340157). doi:10.1155/2011/340157
  3. Caivano M, Gorgoni B, Cohen P, Poli V (2001) The induction of cyclooxygenase-2 mRNA in macrophages is biphasic and requires both CCAAT enhancer- binding protein β (C/EBPβ) and C/EBPδ transcription factors. J Biol Chem 276:48693–48701PubMedCrossRefGoogle Scholar
  4. Chen YT, Tsai SH, Sheu SY, Tsai LH (2010) Ghrelin improves LPS-induced gastrointestinal mobility disturbances: role of NO and prostaglandin E2. Shock 33:205–212PubMedCrossRefGoogle Scholar
  5. Cho I, Kim SG (2009) A novel mitogen-activated protein kinase phosphatase-1 and glucocorticoid receptor (GR) interacting protein-1-dependent combinatorial mechanism of gene transrepression by GR. Mol Endocrinol 23:86–99PubMedCrossRefGoogle Scholar
  6. Cuzzocrea S, Salvemini D (2007) Molecular mechanisms involved in the reciprocal regulation of cyclooxygenase and nitric oxide synthase enzymes. Kidney Int 71:290–297PubMedCrossRefGoogle Scholar
  7. de Boer WA (1996) Topics in Helicobacter pylori infection: focus on a ‘search-and-treat’ strategy for ulcer disease. Scand J Gastroenterol 35(Suppl. 232):4–9Google Scholar
  8. Delghandi MP, Johannessen M, Moens U (2005) The cAMP signaling pathway activates CREB through PKA, p38 and MSK1 in NIH 3T3 Cells. Cell Signal 17:1343–1351PubMedCrossRefGoogle Scholar
  9. Forrester MT, Foster MW, Stamler JS (2007) Assessment and application of the biotin switch technique for examining protein S-nitrosylation under conditions of pharmacologically induced oxidative stress. J Biol Chem 282:13977–13983PubMedCrossRefGoogle Scholar
  10. Grishin AV, Wang J, Hackam F et al (2004) p38 MAP kinase mediates endotoxin-induced expression of cyclooxygenase-2 in enterocytes. Surgery 136:329–335PubMedCrossRefGoogle Scholar
  11. Grishin AV, Wang J, Potoka DA et al (2006) Lipopolysaccharide induces cyclooxygenase-2 in intestinal epithelium via a noncanonical p38 MAPK pathway. J Immunol 176:580–588PubMedGoogle Scholar
  12. Gupta SC, Prasad S, Reuter S et al (2010) Modification of cysteine 179 of IκBα kinase by nimbolide leads to down-regulation of NF-kB-regulated cell survival and proliferative proteins and sensitization of tumor cells to chemotherapeutic agents. J Biol Chem 285:35406–35417PubMedCrossRefGoogle Scholar
  13. Hou DX, Masuzaki S, Hashimoto F et al (2007) Green tea proanthocyanidins inhibit cyclooxygenase-2 expression in LPS-activated mouse macrophages: molecular mechanisms and structure-activity relationship. Arch Biochem Biophys 460:67–74PubMedCrossRefGoogle Scholar
  14. Jaffrey SR, Erdjument-Bromage H, Ferris D, Tempst P, Snyder SH (2001) Protein S-nitrosylation: a physiological signal for neuronal nitric acid. Nat Cell Biol 3:193–197PubMedCrossRefGoogle Scholar
  15. Johannessen M, Delghandi MP, Moens U (2004) What turns CREB on? Cell Signal 16:1211–1227PubMedCrossRefGoogle Scholar
  16. Johnson GL, Lapadat R (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298:1911–1912PubMedCrossRefGoogle Scholar
  17. Joo M, Wright JG, Hu NN et al (2007) Yin yang 1 enhances cyclooxygenase-2 gene expression in macrophages. Am J Physiol Lung Cell Mol Physiol 292:L1219–L1226PubMedCrossRefGoogle Scholar
  18. Kang JL, Lee HW, Kim HJ, Lee HS, Castranova V, Lim CM, Koh Y (2005) Inhibition of Src tyrosine kinase suppresses activation of nuclear factor-κB, and serine and tyrosine phosphorylation of IκB-α in lipopolysaccharide-stimulated Raw 264.7 macrophages. J Toxicol Environ Health A 68:1643–1662PubMedCrossRefGoogle Scholar
  19. Kang KW, Choi SY, Cho MK, Lee CC, Kim SG (2003) Thrombin induces nitric-oxide synthase via Ga12/13-coupled protein kinase C-dependent I-κBα phosphorylation and JNK-mediated I-κBα degradation. J Biol Chem 278:17368–17378PubMedCrossRefGoogle Scholar
  20. Kang YJ, Wingerd BA, Arakawa T, Smith WL (2006) Cyclooxygenase-2 gene transcription in a macrophage model of inflammation. J Immunol 177:8111–8122PubMedGoogle Scholar
  21. Kim SF, Huri DA, Snyder SH (2005) Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science 310:1966–1970PubMedCrossRefGoogle Scholar
  22. Kojima M, Hosoda H, Date Y, Nakazato M, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656–660PubMedCrossRefGoogle Scholar
  23. Lamon BD, Upmacis RK, Deeb RS, Koyuncu H, Haijar D (2010) Inducible nitric oxide synthase gene deletion exaggerates MAPK-mediated cyclooxygenase-2 induction by inflammatory stimuli. Am J Physiol Heart Circ Physiol 299:H613–H623PubMedCrossRefGoogle Scholar
  24. Lodeiro P, Theodoropoulou M, Pardo M, Casanueva FF, Camina JP (2009) c-Src regulates Akt signaling in response to ghrelin via b-arrestin signaling-independent and -dependent mechanism. PLoS One 4(3):e4686. doi:10.1371/journal.pone.0004686 PubMedCrossRefGoogle Scholar
  25. Mori N, Yamada Y, Ikeda S et al (2002) Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. Blood 100:1828–1834PubMedCrossRefGoogle Scholar
  26. Noha SM, Atanasov AG, Schuster D et al (2011) Discovery of a novel IKK-β inhibitor by ligand-based virtual screening techniques. Bioorg Med Chem Lett 21:577–583PubMedCrossRefGoogle Scholar
  27. Osawa H, Nakazato M, Date Y et al (2005) Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. J Clin Endocrinol Metab 90:10–16PubMedCrossRefGoogle Scholar
  28. Perkins ND (2007) Integrating cell-signalling pathways with NF-κB and IKK function. Nat Rev Mol Cell Biol 8:49–62PubMedCrossRefGoogle Scholar
  29. Reider G, Hofmann JA, Hatz RA, Stolte M, Enders GA (2003) Up-regulation of inducible nitric oxide synthase in Helicobacter pylori-associated gastritis may represent an increased risk factor to develop gastric carcinoma of the intestinal type. Int J Med Microbiol 293:403–412CrossRefGoogle Scholar
  30. Romano M, Ricci V, Memoli A et al (1998) Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitro. J Biol Chem 273:28560–285663PubMedCrossRefGoogle Scholar
  31. Rothenbacher D, Inceoglu J, Bode G, Brenner H (2000) Acquisition of Helicobacter pylori infection in a high-risk population occurs within first 2 years of life. J Pediatr 136:744–748PubMedGoogle Scholar
  32. Sibilia V, Pagani F, Rindi G et al (2008) Central ghrelin gastroprotection involves nitric oxide/prostaglandin cross-talk. Br J Pharmacol 154:688–697PubMedCrossRefGoogle Scholar
  33. Singh K, Chaturvedi R, Asim M, Barry DP, Lewis ND, Vitek MP, Wilson KT (2008) The apolipoprotein E-mimetic peptide COG112 inhibits the inflammatory response to Citrobacter rodentium in colonic epithelial cells by preventing NF-κB activation. J Biol Chem 283:16752–16761PubMedCrossRefGoogle Scholar
  34. Slomiany BL, Piotrowski J, Slomiany A (1999) Gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide: down-regulation of nitric oxide synthase-2 and caspase-3 by sulglycotide. Biochem Biophys Res Commun 261:15–20PubMedCrossRefGoogle Scholar
  35. Slomiany BL, Slomiany A (2010) Ghrelin protection against lipopolysaccharide-induced gastric mucosal cell apoptosis involves constitutive nitric oxide synthase-mediated capase-3 S-nitrosylation. Mediat Inflamm 2010:7. doi:10.1155/2010/280464
  36. Slomiany BL, Slomiany A (2011a) Role of constitutive nitric oxide synthase in regulation of Helicobacter pylori-induced gastric mucosal cyclooxygenase-2 activation through S-nitrosylation: mechanism of ghrelin action. Open J Gastroenterol 1:13–22. doi:10.4236/ojgas.2011.12003 CrossRefGoogle Scholar
  37. Slomiany BL, Slomiany A (2011b) Role of ghrelin-induced cSrc activation in modulation of gastric mucosal inflammatory responses to Helicobacter pylori. Inflammopharmacology 19:197–204PubMedCrossRefGoogle Scholar
  38. Slomiany BL, Slomiany A (2011c) Ghrelin suppression of Helicobacter pylori-induced gastric mucosal iNOS is mediated through the inhibition of IKK-β activation by cNOS-dependent S-nitrosylation. Open J Cell Biol 1:1–10. doi:10.4236/ojcb.2011.11001 CrossRefGoogle Scholar
  39. Slomiany BL, Slomiany A (2011d) Helicobacter pylori induces disturbances in gastric mucosal Akt activation through inducible nitric oxide synthase-dependent S-nitrosylation: effect of ghrelin. ISRN Gastroenterol. doi:10.5402/2011/308727 PubMedGoogle Scholar
  40. Slomiany A, Slomiany BL (2011e) Transformations of phosphatidylinositol phosphates in the outer and inner nuclear membrane are linked to synthesis and restitution of cellular membranes. Health 3:187–199. doi:10.4236/health.2011.34035 CrossRefGoogle Scholar
  41. Slomiany BL, Slomiany A (2012) Modulation of gastric mucosal inflammatory responses to Helicobacter pylori by ghrelin: role of cNOS-dependent IKK-β S-nitrosylation in the regulation of COX-2 activation. Am J Mol Biol 2:113–123. doi:10.4236/ajmb.2012.22013 CrossRefGoogle Scholar
  42. Stolte M, Edit S (1996) Helicobacter pylori and evolution of gastritis. Scand J Gastroenterol 3:13–16CrossRefGoogle Scholar
  43. Tanaka H, Fujita N, Tsuruo T (2005) 3-Phosphoinositide-dependent protein kinase-1-mediated IκB Kinase β (IKKB) phosphorylation activates NF-κB signaling. J Biol Chem 280:40965–40973PubMedCrossRefGoogle Scholar
  44. Wilson KT, Fu S, Ramanujam KS, Meltzer SJ (1998) Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett’s esophagus and associated adenocarcinomas. Cancer Res 58:2929–2934PubMedGoogle Scholar
  45. Wroblewski LA, Peek RM, Wilson KT (2010) Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev 23:713–739PubMedCrossRefGoogle Scholar
  46. Xu X, Jhun BS, Ha CH, Jin ZG (2008) Molecular mechanisms of ghrelin-mediated endothelial nitric-oxide synthase activation. Endocrinology 149:4183–4192PubMedCrossRefGoogle Scholar
  47. Ye Y, Martinez JD, Perez-Polo RJ, Lin Y, Uretsky BF, Birnbaum Y (2008) The role of eNOS, iNOS, and NF-κB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastin. Am J Physiol Heart Circ Physiol 295:H343–H351PubMedCrossRefGoogle Scholar
  48. Yu SM, Wu JF, Lin TL, Kuo SC (1997) Inhibition of nitric oxide synthase expression by PPM-18, a novel anti-inflammatory agent, in vitro and in vivo. Biochem J 328:363–369PubMedGoogle Scholar

Copyright information

© Springer Basel AG 2012

Authors and Affiliations

  1. 1.Research Center, Room C875, UMDNJ-NJ Dental SchoolUniversity of Medicine and Dentistry of New JerseyNewarkUSA

Personalised recommendations